Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on April 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

HYDROCHLOROTHIAZIDE

Closed
SPE2DP-26-T-3190Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Hydrochlorothiazide tablets, USP, 25 mg per tablet, are solicited under SPE2DP-26-T-3190 for delivery to USS SHOUP DDG 86 at FPO AP 96678 under FOB Destination terms, with a required delivery window of 20 days after award. The item is a prescription-only oral medication regulated by the FDA, with a 24-month non-extendable shelf life as a Type I (Code M) item, and must be stored at controlled room temperature (20° to 25°C). Each unit of issue is a bottle containing 100 tablets, with a total procurement quantity of two bottles. Packaging must comply with commercial standards including ASTM D3951 for non-hazardous materials, with DLA Master List of Technical and Quality Requirements taking precedence over all commercial standards. Palletization must follow RP001 DLA Packaging Requirements, and all labeling and marking must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items; the U.S. government identification must be removed from non-accepted supplies. The contract mandates electronic invoicing through WAWF, with inspection and acceptance occurring at the destination. Contractors must comply with cybersecurity requirements under 252.204-7012 for safeguarding covered defense information, and are subject to whistleblower protections, restrictions on compensation of former DoD officials, and requirements to report cyber incidents. Hazardous materials labeling, if applicable, must adhere to FED-STD-313 and 29 CFR 1910.1200, with submission of Material Safety Data Sheets required prior to award. Offerors must be registered in SAM, possess valid UEI and CAGE codes, and comply with representations under DFARS clauses regarding covered defense telecommunications equipment and socioeconomic status. The solicitation is issued under simplified acquisition procedures per FAR 52.213-4, with a response deadline of May 6, 2026, and submissions are exclusively required via the DLA Internet Bid Board System (DIBBS). The contract is subject to various clause deviations and applies only to suppliers meeting DLA’s technical specifications, with approved manufacturers including Teva Pharmaceuticals USA, Inc., Golden State Medical Supply, Inc., and Glendale Missionary Baptist Church.

General Info

25 mg hydrochlorothiazide tablets, two bottles, 20-day delivery, FDA-regulated, FOB destination, DLA packaging and labeling, electronic invoicing, cybersecurity compliance.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100192 BOX 1, FPO, AP, 96678, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3190 Medical Supply Chain Pharma FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE TABLETS, USP,.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY, FOR ORAL ADMINISTRATION. EACH TABLET CONTAINS 25 MILLIGRAMS
(MG) OF HYDROCHLOROTHIAZIDE, USP AS THE ACTIVE INGREDIENT.. UNIT OF
ISSUE IS A BOTTLE CONTAINING 100 TABLETS. .. STORE AT 20° TO 25°C (68°
TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE]. LABELING AND MARKING
MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY
2013. 1/9/2017.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3190
SECTION B
.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00172-2083-60 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0331-01 GLENDALE MISSIONARY BAPTIST CHURCH 7EP57 P/N NDC69315-0131-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016574480 0001 BT 2.000
NSN/MATERIAL:6505015544306
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R22994
USS SHOUP DDG 86
UNIT 100192 BOX 1
FPO AP 96678
US
SPE2DP-26-T-3190
SECTION B
PR: 7016574480 PRLI: 0001 CONT’D
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R22994
USS SHOUP DDG 86
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R229946119HM93
RDD: 777
PROJ: EP5 TP 2
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 04
DIC: A41 DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:05/04/2026
SPE2DP-26-T-3190 NSN/Part Number: 6505-01-554-4306 Quantity: 2 BT Purchase Request: 7016574480QTY: 2 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS